Albireo Pharma Inc
ALBO
ALBO was delisted on the 2nd of March, 2023.
70 hedge funds and large institutions have $229M invested in Albireo Pharma Inc in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 9 closing their positions.
135% more call options, than puts
Call options by funds: $101K | Put options by funds: $43K
47% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 19
26% more capital invested
Capital invested by funds: $181M → $229M (+$47.8M)
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
1% more funds holding
Funds holding: 69 → 70 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$4.87M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.48M |
| 3 |
EP
Eversept Partners
New York
|
+$1.2M |
| 4 |
BlackRock
New York
|
+$678K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$656K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
-$4.6M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$2.94M |
| 3 |
Man Group
London,
United Kingdom
|
-$1.97M |
| 4 |
CC
Chicago Capital
Chicago,
Illinois
|
-$945K |
| 5 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$660K |
ALBO Hedge Fund Activity: Q4 2019 in Review
70 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q4 2019, worth a combined $229M — up 26% from $181M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new ALBO positions and 9 closed out — a net gain of 2 holders — while 28 added to existing stakes and 19 trimmed.
The largest buyer was ArrowMark Colorado Holdings, adding an estimated $4.87M. The largest seller was TPG Group Holdings (SBS) Advisors, cutting an estimated $4.6M.
- 70 institutional investors held Albireo Pharma Inc (ALBO) as of Q4 2019, up from 69 in Q3 2019.
- Funds reported $229M of Albireo Pharma Inc stock for Q4 2019, up 26% quarter-over-quarter.
- 11 funds opened new Albireo Pharma Inc positions in Q4 2019 and 9 closed out, a net change of +2 holders.
- The largest Albireo Pharma Inc buyer in Q4 2019 was ArrowMark Colorado Holdings, an estimated $4.87M added.
- The largest Albireo Pharma Inc seller in Q4 2019 was TPG Group Holdings (SBS) Advisors, an estimated $4.6M sold.
Based on aggregated 13F filings for Q4 2019.